| 1 |
30259400 | Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice. | 2019 Jun |
2 |
| 2 |
31422483 | Group I metabotropic glutamate receptors in the primate motor thalamus: subsynaptic association with cortical and sub-cortical glutamatergic afferents. | 2019 Nov |
1 |
| 3 |
29055799 | Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia. | 2018 Jan |
4 |
| 4 |
30271338 | Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | 2018 |
2 |
| 5 |
30439288 | L-DOPA-Induced Motor Impairment and Overexpression of Corticostriatal Synaptic Components Are Improved by the mGluR5 Antagonist MPEP in 6-OHDA-Lesioned Rats. | 2018 Jan-Dec |
1 |
| 6 |
27214664 | A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease. | 2016 Sep |
1 |
| 7 |
24865335 | The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model. | 2014 Jul |
1 |
| 8 |
24960254 | Mavoglurant as a treatment for Parkinson's disease. | 2014 Aug |
2 |
| 9 |
24029003 | Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action. | 2013 Dec |
1 |
| 10 |
21161716 | Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia. | 2011 Dec |
1 |
| 11 |
21484883 | The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of L-DOPA-induced dyskinesias. | 2011 Oct |
1 |
| 12 |
20074579 | Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. | 2010 Jun |
1 |
| 13 |
20132464 | Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys. | 2010 May |
9 |
| 14 |
20452425 | A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys. | 2010 Sep |
1 |
| 15 |
19660528 | Metabotropic glutamate mGluR5 receptor blockade opposes abnormal involuntary movements and the increases in glutamic acid decarboxylase mRNA levels induced by l-DOPA in striatal neurons of 6-hydroxydopamine-lesioned rats. | 2009 Nov 10 |
4 |
| 16 |
17353071 | mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. | 2008 Jul |
1 |
| 17 |
17933546 | Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. | 2008 Jan |
2 |
| 18 |
18690408 | Investigation on tolerance development to subchronic blockade of mGluR5 in models of learning, anxiety, and levodopa-induced dyskinesia in rats. | 2008 Dec |
1 |
| 19 |
17359492 | Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. | 2007 Apr |
2 |
| 20 |
16564428 | Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. | 2006 Apr 14 |
1 |